Streetbeat News

Products Services

ITRI

Itron and PG&E have partnered to enhance electric vehicle (EV) charging through real-time control and grid edge intelligence, making EV charging more accessible and affordable.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

KLIC

Kulicke & Soffa Industries, Inc. (NASDAQ: KLIC) has partnered with ROHM Co., Ltd to develop a new CuFirst™ hybrid bonding process. This collaboration leverages Kulicke & Soffa's Fluxless Thermo-Compression (FTC) process and ROHM's technology innovations to enhance chip-to-wafer hybrid bonding.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

KOP

Koppers (KOP) reported Q3 earnings that exceeded estimates, although revenues fell short. The Railroad and Utility Products and Services segment achieved record sales due to higher pricing.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

IRWD

Ironwood Pharmaceuticals will participate in the Jefferies London Healthcare Conference, with Sravan Emany, COO and CFO, representing the company. The event will be webcast live and available on the company's website.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

LINK

Interlink Electronics, Inc. (Nasdaq: LINK) will have its Vice President of Strategic Alliances, Declan Flannery, present at the Printed Electronics Forum during the electronica 2024 event in Munich, Germany. This highlights the company's active participation in industry events.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

SSKN

STRATA Skin Sciences, Inc. (NASDAQ: SSKN) reported its financial results for Q3 2024, highlighting its focus on developing and marketing innovative dermatologic treatment products.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

GWH

ESS Tech, Inc. reported its financial results for the third quarter of 2024, highlighting its strong market position in long-duration energy storage systems for commercial and utility-scale applications.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

XENE

Xenon Pharmaceuticals Inc. (Nasdaq: XENE) will present at two upcoming investor conferences, highlighting its focus on neuroscience therapeutics.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

ANTX

AN2 Therapeutics, Inc. (Nasdaq: ANTX) reported its Q3 2024 financial results and provided an update on the EBO-301 trial, highlighting progress in its boron chemistry pipeline. The company focuses on developing novel small molecule therapeutics.

Portfolio Pulse from

November 13, 2024 | 9:15 pm

ATRA

Atara Biotherapeutics will participate in the Stifel 2024 Healthcare Conference, with CEO Cokey Nguyen speaking in a fireside chat. The company is known for its T-cell immunotherapy platform targeting cancer and autoimmune diseases.

Portfolio Pulse from

November 13, 2024 | 9:15 pm